Interleukin-4 production in epstein-barr virus-transformed B cell lines from peripheral mononuclear cells of patients with atopic dermatitis

Journal of Interferon and Cytokine Research

Volumn 17, Issue 10, 1997, Pages 597-602

  Ohnishi, Eiko ^a   Iwata, Tsutomu ^b   Inouye, Sakae ^a   Kurata, Takeshi ^a   Sairenji, Takeshi ^a,c  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 4; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; ATOPIC DERMATITIS; CELL CULTURE; CELL LINE; CELL TRANSFORMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL;

EID: 0030771491     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.597     Document Type: Article

References (31)

1. COOPER, K. (1993). Atopic dermatitis: recent trends in pathogenesis and therapy. J. Invest. Dermatol. 101, 155-163.
2. ISHIZAKA, K., ISHIZAKA, T., and HORNBROOK, M.M. (1966). Physicochemical properties of reaginic antibody. J. Immunol. 97, 75-85.
3. GEHA, R.S. (1992). Regulation of IgE synthesis in humans. J. Allergy Clin. Immunol. 90, 143-150.
4. DE VRIES, J.E. (1994). Novel fundamental approaches to intervening in IgE-mediated allergic diseases. J. Invest. Dermatol. 102, 141-144.
5. MOSMANN, T.R., CHERWINAKI, H., BOND, M.W., GIEDLIN, M.H., and COFFMAN, R. (1986). Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
6. GAJEWSKI, T.F., and FITCH, F. (1988). Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140, 4245-4252.
7. THYPHRONITIS, G., TSOKOS, G.C., JUNE, C.H., LEVINE, A.D., and FINKELMAN, F.D. (1989). IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon-γ. Proc. Natl. Acad. Sci. USA 86, 5580-5584.
8. REEDMAN, B.M., and KLEIN, G. (1978). Cellular localization of an Epstein-Barr virus (EBV) associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer 11, 499-520.
9. SAKAGUCHI, M., INOUYE, S., MIYAZAWA, H., and TAMURA, S. (1989). Measurement of antigen-specific mouse IgE by fluorometric reverse (IgE-capture) ELISA. J. Immunol. Methods 116, 181-187.
10. KOHASE, M., YAMAZAKI, S., SHISHIDO, A., and KONO, R. (1982). Potency standardization of human interferon of clinical trials. In: The Clinical Potential of Interferons. R. Kono and J. Vilcek (eds.) Tokyo: University of Tokyo Press, pp. 299-309.
11. ONISHI, E., NATORI, K., and YAMAZAKI, S. (1991). The antiviral effect of phorbol ester and calcium ionophore A23187 is not mediated by interferons. J. Interferon Res. 11, 171-175.
12. TAKEDA, N., SAKAE, K., AGBOATWALLA, S., ISOMURA, R., HONDO, T., and INOUYE, S. (1994). Differentiation between wild and vaccine-derived strain of poliovirus by stringent microplate hybridization of PCR products. J. Clin. Microbiol. 32, 202-204.
13. BRERNNER, C.A., DANIEL, S.L., and ADLER, R.R. (1991). Cytokine mapping: observation and quantification of cytokine mRNA in small numbers of cells using the polymerase chain reaction. In: Cytokines. A Practical Approach. Oxford, New York, Tokyo: IRL Press at Oxford University Press, pp. 51-59.
14. HINUMA, Y., KONN, M., YAMAGUCHI, Y., WUDARSKI, D.J. Jr., BLAKESLEE, J.R. Jr., and GRACE, J.T. Jr. (1967). Immunofluorescence and herpes virus particles in P3HR-1 Burkitt lymphoma cell line. J. Virol. 1, 1045-1051.
15. GEY, G.O., COFFMAN, W.D., and KUBICEK, M.T. (1952). Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12, 264-265.
16. PAUL, W.E. (1989). Pleiotrophy and redundancy: T cell-derived lymphokines in the immune response. Cell 57, 521-524.
17. MOSMAN, T.R., and COFFMAN, R.L. (1989). Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
18. PLAUT, M., PIERCE, J.H., WATSON, C.J., HANLEY-HYDE, J., NORDAN, R.P., and PAUL, W.E. (1989). Mast cell lines produce lymphokines in response to cross linkage of Fc∈RI or to calcium ionophores. Nature 339, 64-67.
19. + bone marrow and splenic non-B, non-T cells are highly enriched in the capacity to produce IL-4 in response to immobilized IgE, IgG2a, or ionomycin. J. Immunol. 147, 903-909.
20. + T cells. J. Immunol. 148, 2291-2299.
21. TANG, H., MATTHES, T., CARBALLIDO-PERRIG, N., ZUBLER, R.H., and KINDLER, V. (1993). Differential induction of T cell cytokine mRNA in Epstein-Barr virus-transformed B cell clones: constitutive and inducible expression of interleukin-4 mRNA. Eur. J. Immunol. 23, 899-903.
22. ZUR HAUSEN, H., NEIL, F.J.O., and FREESE, U.K. (1978). Persisting oncogenic herpesvirus induced by the tumor promoter TPA. Nature 272, 373-375.
23. BIRD, A.G., McLACHLAN, S.M., and BRITTON, S. (1981). Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B cell lines. Nature 289, 300-301.
24. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J. Invest. Dermatol. 97, 389-394.
25. JUJO, K., RENZ, H., ABE, J., GELFAND, E.W., and LEUNG, D.Y. (1992). Decreased gamma interferon and increased interleukin-4 production promote IgE synthesis in atopic dermatitis. J. Allergy Clin. Immunol. 90, 323-331.
26. RENZ, H., JUJO, K., BRADLEY, K.L., DOMENICO, J., GELFAND, E.W., and LEANG, D.Y.M. (1992). Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J. Invest. Dermatol. 99, 403-408.
27. COFFMAN, R.L., OHARA, J., BOND, M., CARTY, J., ZLOTNICK, A., and PAL, W.E. (1986). B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J. Immunol. 136, 4538-4541.
28. FINKELMAN, F.D., KATONA, I., URBAN, J., SNAPPER, C.M., OHARA, J., and PAUL, W.E. (1986). Suppression of in vivo polyclonal IgE responses monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proc. Natl. Acad. Sci. USA 83, 9675-9678.
29. TAKADA, K., and ONO, Y. (1989). Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63, 445-449.
30. PULVERTAFT, R.J.V. (1965). A study of malignant tumors in Nigeria by short-term tissue culture. J. Clin. Pathol. 18, 261-271.
31. MILLER, G., and LIPMAN, M. (1973). Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70, 190-194.